Corrigendum to: CYP2B6 Genotype and Weight Gain Differences Between Dolutegravir and Efavirenz.

Griesel, Rulan; Maartens, Gary; Chirehwa, Maxwell; Sokhela, Simiso; Akpomiemie, Godspower; Moorhouse, Michelle; Venter, Francois; Sinxadi, Phumla

Griesel, Rulan; Maartens, Gary; Chirehwa, Maxwell; Sokhela, Simiso; Akpomiemie, Godspower; Moorhouse, Michelle; Venter, Francois; Sinxadi, Phumla.

Afiliación

Griesel R; Division of Clinical Pharmacology, Department of Medicine, University of Cape Town, Cape Town, South Africa.
Maartens G; Wellcome Centre for Infectious Diseases Research in Africa, Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa.
Chirehwa M; Division of Clinical Pharmacology, Department of Medicine, University of Cape Town, Cape Town, South Africa.
Sokhela S; Wellcome Centre for Infectious Diseases Research in Africa, Institute of Infectious Disease and Molecular Medicine, University of Cape Town, Cape Town, South Africa.
Akpomiemie G; Division of Clinical Pharmacology, Department of Medicine, University of Cape Town, Cape Town, South Africa.
Moorhouse M; Ezintsha, Wits Reproductive Health and HIV Institute, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
Venter F; Ezintsha, Wits Reproductive Health and HIV Institute, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
Sinxadi P; Ezintsha, Wits Reproductive Health and HIV Institute, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.

Clin Infect Dis ; 74(4): 755, 2022 Mar 01.

Article en En | MEDLINE | ID: mdl-35099526

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Idioma: En Revista: Clin Infect Dis Asunto de la revista: DOENCAS TRANSMISSIVEIS Año: 2022 Tipo del documento: Article País de afiliación: Sudáfrica

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google